Prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic toxicity in mice by MDL 72145, a selective inhibitor of MAO-B
- 1 April 1986
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 38 (16) , 1459-1462
- https://doi.org/10.1016/0024-3205(86)90558-8
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Studies on the Oxidation of the Dopaminergic Neurotoxin 1‐Methyl‐4‐Phenyl‐1,2,5,6‐Tetrahydropyridine by Monoamine Oxidase BJournal of Neurochemistry, 1985
- 1-methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in cultureNeuroscience Letters, 1985
- Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationshipsJournal of Medicinal Chemistry, 1985
- VI. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: Relationships between monoamine oxidase, MPTP metabolism and neurotoxicityLife Sciences, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- MDL 72145, an Enzyme-Activated Irreversible Inhibitor with Selectivity for Monoamine Oxidase Type BJournal of Neurochemistry, 1984
- Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain & heartLife Sciences, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983